ScoreWhy is BioArctic AB ?
1
High Management Efficiency with a high ROE of 15.35%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of -8.97
3
Healthy long term growth as Net Sales has grown by an annual rate of 83.05% and Operating profit at 84.23%
4
Flat results in Mar 25
- OPERATING CASH FLOW(Y) Lowest at SEK -190.14 MM
- CASH AND EQV(HY) Lowest at SEK 1,337.48 MM
- DEBT-EQUITY RATIO (HY) Highest at -26.25 %
5
With ROE of 52.40%, it has a fair valuation with a 13.23 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 58.18%, its profits have risen by 1308.6% ; the PEG ratio of the company is 0
6
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
7
Market Beating Performance
- The stock has generated a return of 58.18% in the last 1 year, much higher than market (OMX Stockholm 30) returns of 9.24%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to BioArctic AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is BioArctic AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
BioArctic AB
75.59%
0.53
61.19%
OMX Stockholm 30
8.01%
0.51
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
83.05%
EBIT Growth (5y)
84.23%
EBIT to Interest (avg)
-8.97
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.50
Tax Ratio
3.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
17.86%
ROE (avg)
15.35%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
13.23
EV to EBIT
19.58
EV to EBITDA
19.58
EV to Capital Employed
186.26
EV to Sales
13.46
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
951.43%
ROE (Latest)
52.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend41What is working for the Company
ROCE(HY)
Highest at 61.64%
NET SALES(Q)
Highest at SEK 1,289.61 MM
RAW MATERIAL COST(Y)
Fallen by -7.27% (YoY
OPERATING PROFIT(Q)
Highest at SEK 1,147.53 MM
OPERATING PROFIT MARGIN(Q)
Highest at 88.98 %
PRE-TAX PROFIT(Q)
Highest at SEK 1,065.98 MM
NET PROFIT(Q)
Highest at SEK 1,021.47 MM
EPS(Q)
Highest at SEK 11.55
-12What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at SEK -190.14 MM
CASH AND EQV(HY)
Lowest at SEK 1,337.48 MM
DEBT-EQUITY RATIO
(HY)
Highest at -26.25 %
INTEREST(Q)
Highest at SEK 14.23 MM
Here's what is working for BioArctic AB
Net Sales
At SEK 1,289.61 MM has Grown at 1,904.43%
over average net sales of the previous four periods of SEK 64.34 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (SEK MM)
Pre-Tax Profit
At SEK 1,065.98 MM has Grown at 2,349.86%
over average net sales of the previous four periods of SEK -47.38 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK 1,021.47 MM has Grown at 2,407.37%
over average net sales of the previous four periods of SEK -44.27 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (SEK MM)
Net Sales
Highest at SEK 1,289.61 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (SEK MM)
Operating Profit
Highest at SEK 1,147.53 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SEK MM)
Operating Profit Margin
Highest at 88.98 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at SEK 1,065.98 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
Highest at SEK 1,021.47 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
EPS
Highest at SEK 11.55
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Raw Material Cost
Fallen by -7.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for BioArctic AB
Operating Cash Flow
Lowest at SEK -190.14 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SEK MM)
Interest
At SEK 14.23 MM has Grown at 2,059.94%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Interest
Highest at SEK 14.23 MM
in the last five periods and Increased by 2,059.94% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Cash and Eqv
Lowest at SEK 1,337.48 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -26.25 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
